Xin Sheng Xu
Vorsitzender bei Sinotau Pharmaceuticals Group
Ursprung des Netzwerks ersten Grades von Xin Sheng Xu
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sinotau Pharmaceuticals Group
 Sinotau Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Sinotau Pharmaceuticals Group is a Chinese pharmaceutical company founded in 2005 that focuses on becoming an overall solution provider in the field of neurological degenerative lesions. The company is based in Beijing, China, and has subsidiaries in China. The company offers a range of products and services, including nuclear medicine, radioactive drug development, high-quality production, and clinical academic promotion. The company has a drug research and development technology platform and monoclonal antibody research and development drug technology platform, supplemented by generic drug research and development, production, and sales. The company also offers targeted drugs, precise diagnosis, and precision therapy drugs guided by research, development, and commercial molecular images.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Beijing Sinotau Pharmaceutical Technology Co., Ltd.
 Beijing Sinotau Pharmaceutical Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sinotau Pharmaceuticals Group, Beijing Sinotau Pharmaceutical Technology Co., Ltd. is a company founded in 2005 that engages in research & development, manufacture and promotion of radiopharmaceuticals and biological antibody drugs. The company is based in Beijing, China.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xin Sheng Xu
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SINOCELLTECH GROUP LIMITED | Miscellaneous Commercial Services | Director/Board Member | |
| Cheung Kong Graduate School of Business | College/University | Masters Business Admin | |
| Shenyang Pharmaceutical University | College/University | Undergraduate Degree | |
Beijing Shenogen Pharma Group Ltd.
 Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Biotechnology | Director/Board Member | |
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Pharmaceuticals: Major | Director/Board Member | |
| Jacobio Hk Pharmaceuticals Co. Ltd. | Director/Board Member | ||
| Asia Baokang Pharmaceutical Consulting Beijing Co. Ltd. | Corporate Officer/Principal | ||
| Suzhou Qiyuan Equity Investment Mgmt Partnership Enterprise LP | Corporate Officer/Principal | ||
Suzhou Cure Genetics Co., Ltd.
 Suzhou Cure Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Cure Genetics Co., Ltd. is a biotechnology company based in Suzhou, China. The Chinese company specializes in developing gene and cell therapy for tumors and genetic diseases. | Pharmaceuticals: Major | Director/Board Member | |
| Suzhou Keyue Biotech Co. Ltd. | Director/Board Member | ||
| ABBISKO CAYMAN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| SINO BIOLOGICAL,INC. | Pharmaceuticals: Major | Director/Board Member | |
| Guangdong Xiantong Molecular Imaging Technology Co. Ltd. | Director/Board Member | ||
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor |
Statistik
International
| China | 14 |
| Cayman Islands | 2 |
| Hong Kong | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
| Finance | 2 |
Operativ
| Director/Board Member | 12 |
| President | 2 |
| Corporate Officer/Principal | 2 |
| Private Equity Investor | 1 |
| Masters Business Admin | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Yan Min Tang | 17 |
- Börse
- Insiders
- Xin Sheng Xu
- Unternehmensverbindungen
